Medication info
Exforge 5/160mg (Amlodipine Besilate, Valsartan)

Exforge 5/160mg (Amlodipine Besilate, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Novartis Korea Ltd.
Appearance
Dark yellow oval film-coated tablet
Packaging
28 tablets (14 tablets/PTP packaging X 2), 28 tablets (7 tablets/PTP packaging X 4)
Approval status
Active

MFDS item code 200703803 · Approved 2007.04.03 · Insurance code 653600850

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients 65 years of age or older: Exercise caution when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients younger than 18 years; therefore, its use is not recommended.

Ingredients

Importer
Novartis Korea Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or valsartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients 65 years of age or older: Exercise caution when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients younger than 18 years; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, use should be discontinued immediately if pregnancy is confirmed. Patients with allergies to any of the active ingredients or related medications, pregnant or breastfeeding women, and those with severe renal or liver dysfunction should not use this medication. Patients with low sodium or fluid levels in the body should carefully check their condition before taking this medication, and during use, blood pressure and condition should be monitored closely. Patients with high potassium levels should frequently check their potassium levels when taking this medication with potassium-increasing medications. Patients with kidney problems or those who have received a kidney transplant should closely monitor kidney function when taking this medication, and should discontinue use immediately if symptoms of angioedema appear. Patients recovering from heart failure or myocardial infarction should carefully monitor changes in kidney function while taking this medication and be prepared for potential heart failure worsening. This medication lowers blood pressure, so an overdose can lead to dizziness or severe hypotension, which may require immediate medical attention. Dizziness or fatigue may occur while driving or operating machinery, so caution is advised. There may be interactions if taken with other medications, especially potassium supplements, diuretics, and anti-inflammatory drugs, so it is advisable to consult a doctor or pharmacist before taking them together. It is safest for women who are pregnant or planning to become pregnant, as well as breastfeeding women, to avoid using this medication. This medication is not recommended for children under 18 years of age, as its safety and efficacy have not been adequately established.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, rash, joint swelling, lower back pain, arthritis, muscle cramps, lethargy, frequent urination, polyuria, erectile dysfunction, edema, angioedema, facial swelling, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, elevated serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenic purpura, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbance, peripheral neuropathy, muscular hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, phototoxic reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervous hypersensitivity, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a closed container to protect it from air and moisture. It is recommended to maintain storage temperature between 1 degree Celsius and 30 degrees Celsius.

Appearance and packaging

Appearance

Dark yellow oval film-coated tablet

Package unit

28 tablets (14 tablets/PTP packaging X 2), 28 tablets (7 tablets/PTP packaging X 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.